Royce & Associates’s BioSpecifics Technologies Corp. BSTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-132,058
| Closed | -$6.98M | – | 1060 |
|
|
2020
Q3 | $6.98M | Sell |
132,058
-2,277
| -2% | -$141K | 0.08% | 390 |
|
|
2020
Q2 | $8.23M | Sell |
134,335
-5,009
| -4% | -$290K | 0.09% | 321 |
|
|
2020
Q1 | $7.88M | Sell |
139,344
-31,950
| -19% | -$1.82M | 0.11% | 251 |
|
|
2019
Q4 | $9.75M | Sell |
171,294
-30,843
| -15% | -$1.64M | 0.09% | 327 |
|
|
2019
Q3 | $10.8M | Buy |
202,137
+161,215
| +394% | +$9.38M | 0.1% | 291 |
|
|
2019
Q2 | $2.44M | Buy |
40,922
+46
| +0.1% | +$2.9K | 0.02% | 679 |
|
|
2019
Q1 | $2.55M | Sell |
40,876
-11,265
| -22% | -$745K | 0.02% | 671 |
|
|
2018
Q4 | $3.16M | Sell |
52,141
-6,944
| -12% | -$415K | 0.03% | 606 |
|
|
2018
Q3 | $3.46M | Sell |
59,085
-5,254
| -8% | -$268K | 0.02% | 691 |
|
|
2018
Q2 | $2.89M | Buy |
64,339
+107
| +0.2% | +$4.6K | 0.02% | 747 |
|
|
2018
Q1 | $2.85M | Buy |
64,232
+16,194
| +34% | +$680K | 0.02% | 758 |
|
|
2017
Q4 | $2.08M | Buy |
48,038
+8,521
| +22% | +$383K | 0.01% | 839 |
|
|
2017
Q3 | $1.84M | Buy |
39,517
+117
| +0.3% | +$5.6K | 0.01% | 855 |
|
|
2017
Q2 | $1.95M | Hold |
39,400
| – | – | 0.01% | 849 |
|
|
2017
Q1 | $2.16M | Sell |
39,400
-5,600
| -12% | -$296K | 0.01% | 837 |
|
|
2016
Q4 | $2.51M | Sell |
45,000
-30,600
| -40% | -$1.47M | 0.02% | 766 |
|
|
2016
Q3 | $3.45M | Sell |
75,600
-19,500
| -21% | -$783K | 0.02% | 688 |
|
|
2016
Q2 | $3.8M | Buy |
95,100
+20,510
| +27% | +$751K | 0.03% | 669 |
|
|
2016
Q1 | $2.6M | Buy |
74,590
+28,390
| +61% | +$1.04M | 0.02% | 783 |
|
|
2015
Q4 | $1.99M | Hold |
46,200
| – | – | 0.01% | 854 |
|
|
2015
Q3 | $2.01M | Hold |
46,200
| – | – | 0.01% | 870 |
|
|
2015
Q2 | $2.38M | Sell |
46,200
-2,400
| -5% | -$102K | 0.01% | 902 |
|
|
2015
Q1 | $1.9M | Hold |
48,600
| – | – | 0.01% | 954 |
|
|
2014
Q4 | $1.88M | Sell |
48,600
-38,000
| -44% | -$1.45M | 0.01% | 982 |
|
|
2014
Q3 | $3.06M | Sell |
86,600
-13,400
| -13% | -$393K | 0.01% | 918 |
|
|
2014
Q2 | $2.7M | Hold |
100,000
| – | – | 0.01% | 993 |
|
|
2014
Q1 | $2.59M | Hold |
100,000
| – | – | 0.01% | 1009 |
|
|
2013
Q4 | $2.17M | Hold |
100,000
| – | – | 0.01% | 1054 |
|
|
2013
Q3 | $1.95M | Hold |
100,000
| – | – | 0.01% | 1077 |
|
|
2013
Q2 | $1.56M | Buy |
+100,000
| New | +$1.61M | ﹤0.01% | 1091 |
|
Other funds holding BSTC
Royce & Associates's BSTC Position: Q4 2020 in Review
Royce & Associates sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 132,058 shares — an estimated $6.98M sold.
Royce & Associates first reported a position in BSTC in Q2 2013 and held it in 30 quarters. The position peaked at $10.8M in Q3 2019. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.
- Royce & Associates reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
- Royce & Associates sold 132,058 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $6.98M.
- Royce & Associates first reported a position in BioSpecifics Technologies Corp. in Q2 2013 and held it in 30 quarters.
- Royce & Associates's BioSpecifics Technologies Corp. position peaked at $10.8M in Q3 2019.
- 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.
Based on Royce & Associates's 13F filing for Q4 2020, filed 8 Feb 2021.